A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis.
作者信息
Piscitelli Stephen C, Pavel Ana B, McHale Kimberly, Jett John E, Collins Jon, Gillmor Dawn, Tabolt Glenn, Li Randall, Song Teresa, Zhang Ning, Tallman Anna M, Guttman-Yassky Emma
机构信息
Dermavant Sciences, Inc, Durham, North Carolina, USA.
Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Biomedical Engineering, The University of Mississippi, Oxford, Mississippi, USA.
出版信息
J Invest Dermatol. 2021 Jul;141(7):1847-1851. doi: 10.1016/j.jid.2020.11.031. Epub 2021 Jan 22.
PMID:33493530
Abstract
摘要
Zotero 插件